NCT07092241Active, not recruiting
The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies
Source: ClinicalTrials.gov · Last updated 29 Jul 2025
Brief summary (registry, in English)
pediatric migraine
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 8 Jul 2025
- Start date
- 1 Jan 2023
- Primary completion date
- 20 Mar 2024
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Migraine
- NCT number
- NCT07092241
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Jan 2023 to the primary completion date, 20 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving antibiotic treatment for the past 2 weeks
- Receiving probiotic treatment for the past one month
Other
- Multiple congenital anomalies, for instance, meningoencephalocele, chromosomal anomalies, and congenital intestinal atresia, etc.
- Mental retardation that is difficult to describe the symptoms
Who the study is looking for
- clinical diagnosis with migraine
Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.